Multi-Center Study
PRIMO Clinical Study
Single-arm, multi-center, clinical follow-up study
A post-market, single-arm, multi-center, clinical follow-up study to monitor the safety and performance of the Symani Surgical System in microsurgical reconstructive procedures in a real-life setting.
Currently enrolling.
The PRIMO study is registered in the ClinicalTrials.gov database with identifier NCT04843436. Detailed information can be found using the link below.
PRIMO Study Centers
| Investigational Site | Location | Principal Investigator |
|---|---|---|
| Fachklinik Hornheide | Münster, Germany | Dr. Maximilian Kückelhaus |
| Universitätsklinikum Schleswig-Holstein | Kiel, Germany | Dr. Jorg Wiltfang |
| Hospital de la Santa Creu y San Pau | Barcelona, Spain | Dr. Jaume Masia |
| Istituto Ortopedico Rizzoli | Bologna, Italy | Dr. Francesco Mori |
| Universitair Ziekenhuis Brussel | Brussels, Belgium | Dr. Moustapha Hamdi |
| Azienda Ospedaliera Universitaria Careggi | Florence, Italy | Dr. Giulio Menichini |
| Uniklinikum Salzburg | Salzburg, Austria | Dr. Simon Enzinger |
| Universitätsspital Zürich | Zürich, Switzerland | Dr. Nicole Lindenblatt |
You might also be interested in…
MMI
5022 Gate Parkway,
Building 500,
Jacksonville, FL 32256
5022 Gate Parkway,
Building 500,
Jacksonville, FL 32256
Product Information: connect@mmimicro.com
Symani Support: techsupport@mmimicro.com
The Symani Surgical System is authorized for use in the U.S. by the FDA and is a CE marked medical device. Clinical indications vary by geography. Refer to global indications for more information. © 2024 Medical Microinstruments, Inc. All Rights Reserved.